全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:H. Sasaki , K. Tamura , Y. Naito ...
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (4), pp.793-800Springer
摘要:Cancer chemotherapy is associated with a variety of side effects/adverse events. It is very important that patients adhere to the planned chemotherapy regimen, which necessitates a minimum of side effects and that these side effects be kept under control. We have investigate...
作者:Satoshi Nagayama , Suguru Hasegawa , Koya Hida ...
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (2), pp.316-323Springer
摘要:Although liver resection combined with preoperative chemotherapy is expected to improve outcomes of patients with resectable colorectal liver metastasis (CRLM), there is as yet insufficient clinical evidence supporting the efficacy of preoperative systemic chemotherapy. The aim o...
作者:Yi-Jun Kim , Hyeon Kang Koh , Eui Kyu Chie ...
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (6), pp.1069-1075Springer
摘要:To investigate the significance of carbohydrate antigen 19-9 (CA19-9) levels for survival in locally advanced pancreatic cancer (LAPC) treated with concurrent chemoradiotherapy (CCRT).
作者:Yosuke Miura , Kyoichi Kaira , Reiko Sakurai ...
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (5), pp.872-879Springer
摘要:Glucose-regulated protein (GRP) 78/immunoglobulin heavy chain binding protein (BiP) is a member of the endoplasmic reticulum chaperone family, and its role in various types of human malignancies has recently been investigated. However, the clinicopathological characteristics of G...
作者:Hironori Fukuda , Tsunenori Kondo , Toshio Takagi ...
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (4), pp.767-773Springer
摘要:The clinical benefit of targeted molecular therapy (TMT) for an inferior vena cava (IVC) tumor thrombus associated with renal cell carcinoma (RCC) is unclear. The aim of the present study was to assess the change in IVC thrombus height during TMT and to identify the factors assoc...
作者:Stephanie Belaiche , Bertrand Décaudin , Sébastien Dharancy ...
来源:[J].International Journal of Clinical Pharmacy(IF 0.859), 2017, Vol.39 (3), pp.582-593Springer
摘要:Background Medication non-adherence is a major issue after transplant that can lead to misdiagnosis, rejection, poor health affecting quality of life, graft loss or death. Several estimations of adherence and related factors have previously been described but conclusions lea...
作者:László Horváth , Klára Fekete , Sándor Márton ...
来源:[J].International Journal of Clinical Pharmacy(IF 0.859), 2017, Vol.39 (2), pp.459-467Springer
摘要:Background Although defined daily doses (DDD) for antiepileptic drugs (AED) have been assigned only in combination therapy, based on the literature, most patients take them in monotherapy. Furthermore, discrepancies between DDD and prescribed daily dose (PDD) were observed. ...
作者:Alireza Nazari , Hossein Khorramdelazad , Gholamhossein Hassanshahi
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (6), pp.991-1000Springer
摘要:CXC chemokine ligand 12 (CXCL12) is an important member of the CXC subfamily of chemokines, and has been extensively studied in various human body organs and systems, both in physiological and clinical states. Ligation of CXCL12 to CXCR4 and CXCR7 as its receptors on peripheral i...
作者:Naoki Fujita , Takuya Koie , Chikara Ohyama ...
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (6), pp.1087-1093Springer
摘要:The optimal treatment for high-risk prostate cancer (PCa) remains to be established. We previously reported favorable, biochemical recurrence-free survival in high-risk PCa patients treated with a neoadjuvant gonadotropin-releasing hormone agonist or antagonist and estramustine p...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×